Long-acting Cabotegravir Shot Prevents HIV Among Women

For the first time, a long-acting shot has been shown to prevent HIV among women in a large-scale trial, the National Institute of Allergy and Infectious Diseases (NIAID) said in a statement. The institute announced interim phase 3 trial results for an injectable form of cabotegravir, an investigational HIV drug.
Source: JAMA - Category: General Medicine Source Type: research